Panic Disorder Market Grows at 4.18% CAGR to 2035

Is the Panic Disorder Market Prepared to Meet the Growing Global Mental Health Burden?

Panic Disorder Market: In-Depth Global Analysis and Forecast

The Panic Disorder Market has become an increasingly important segment of the global mental health landscape as anxiety-related conditions continue to rise worldwide. Panic disorder, characterized by recurrent and unexpected panic attacks accompanied by persistent fear and behavioral changes, significantly affects quality of life, productivity, and overall wellbeing. Growing awareness of mental health, reduced stigma, and improved access to care are reshaping how panic disorder is diagnosed and treated.

In 2025, the panic disorder market across the seven major markets was valued at USD 10.11 billion. Supported by greater emphasis on mental health care, expanded therapeutic options, and better diagnosis rates, the market is projected to grow at a CAGR of 4.18% from 2026 to 2035, reaching approximately USD 15.23 billion by 2035.

Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/panic-disorder-market/requestsample.

Understanding Panic Disorder: A Clinical Overview

Panic disorder is a mental health condition marked by sudden episodes of intense fear or discomfort, often accompanied by physical symptoms such as palpitations, sweating, chest pain, dizziness, and shortness of breath. These panic attacks are frequently unexpected and may lead to persistent concern about future attacks.

Key characteristics include:

Recurrent panic attacks

Anticipatory anxiety and avoidance behavior

High comorbidity with depression and other anxiety disorders

Significant impact on social and occupational functioning

The disorder often begins in adolescence or early adulthood and is more prevalent among women, making early diagnosis and effective long-term management critical.

Panic Disorder Market Overview

The panic disorder market includes pharmacological therapies, psychotherapy interventions, and supportive care approaches aimed at reducing symptom severity and preventing relapse. Historically, treatment relied heavily on medications; however, integrated care models combining drugs and therapy are now considered best practice.

Key aspects shaping the market include:

Growing diagnosis rates due to improved mental health screening

Expanding use of cognitive and behavioral therapies

Increasing prescription of antidepressants and anxiolytics

Rising healthcare spending on mental health services

The market remains moderately fragmented, with established pharmaceutical companies and growing interest in novel therapeutic approaches.

Key Growth Drivers of the Panic Disorder Market

Rising Mental Health Awareness

Global campaigns and policy initiatives promoting mental health awareness have encouraged individuals to seek diagnosis and treatment earlier.

Increasing Prevalence of Anxiety Disorders

Stressful lifestyles, urbanization, social pressures, and post-pandemic psychological effects have contributed to higher anxiety disorder prevalence.

Improved Access to Mental Healthcare

Telepsychiatry, digital therapy platforms, and expanded insurance coverage have improved access to treatment, particularly in developed markets.

Advancements in Pharmacological Therapies

Newer antidepressants and anxiolytics with improved safety and tolerability profiles support long-term treatment adherence.

Growing Acceptance of Psychotherapy

Cognitive-behavioral therapy (CBT) is increasingly recognized as a first-line treatment, boosting therapy-related market segments.

Emerging Trends in the Panic Disorder Market

Integration of Digital Mental Health Solutions

Mobile apps, online CBT programs, and virtual therapy sessions are expanding reach and lowering treatment barriers.

Shift Toward Personalized Treatment

Clinicians are tailoring treatment plans based on symptom severity, comorbidities, and patient preferences.

Reduced Reliance on Long-Term Benzodiazepines

Due to dependency concerns, prescribers are favoring SSRIs, SNRIs, and psychotherapy over long-term benzodiazepine use.

Focus on Comorbid Conditions

Treatment approaches increasingly address coexisting disorders such as depression, PTSD, and substance use disorders.

Growing Research into Novel Mechanisms

Pharmaceutical research is exploring non-traditional pathways to improve treatment outcomes and reduce side effects.

Panic Disorder Market Segmentation Analysis

By Type

Panic disorder frequently coexists with other psychiatric conditions, influencing diagnosis and treatment strategies.

Agoraphobia - Commonly associated with panic disorder, leading to avoidance of public spaces

Social Anxiety Disorder (SAD) - Shares overlapping symptoms and treatment approaches

Obsessive-Compulsive Disorder (OCD) - Often co-diagnosed, complicating management

Bipolar Disorder - Requires careful treatment to avoid mood destabilization

Post-Traumatic Stress Disorder (PTSD) - Panic symptoms often triggered by trauma-related cues

Specific Phobias and Generalized Anxiety Disorder (GAD) - Represent a large comorbid patient pool

Major Depressive Disorder (MDD) - One of the most frequent comorbidities

Others - Includes mixed anxiety and mood disorders

By Therapy

Cognitive-Behavioral Therapy (CBT)

CBT is considered the gold standard non-pharmacological treatment. It focuses on cognitive restructuring and exposure techniques to reduce panic symptoms.

Electroconvulsive Therapy (ECT)

ECT is rarely used and typically reserved for severe, treatment-resistant cases with comorbid depression.

By Drug Class

Pharmacotherapy remains a cornerstone of panic disorder management.

Benzodiazepines (BZD) - Provide rapid symptom relief but limited by dependence risks

Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) - Widely used for long-term management

Monoamine Oxidase Inhibitors (MAOIs) - Effective but limited by dietary and safety concerns

Antidepressants - Broad category including SSRIs as first-line agents

Tricyclic Antidepressants (TCAs) - Effective but associated with more side effects

Pregabalin - Used off-label for anxiety symptom control

Buspirone - Non-sedative anxiolytic option

Sertraline - A commonly prescribed SSRI for panic disorder

Others - Includes emerging and adjunctive therapies

Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/panic-disorder-market.

By Route of Administration

Oral - Dominates the market due to convenience and chronic use suitability

Parenteral - Limited use, primarily in acute or inpatient settings

Regional Analysis of the Panic Disorder Market

United States

The U.S. represents the largest share of the panic disorder market due to high awareness, advanced mental healthcare infrastructure, and widespread access to pharmacological and psychological therapies.

United Kingdom

Government-led mental health initiatives and increased availability of CBT through public healthcare systems support market growth.

Germany

Germany's strong healthcare reimbursement framework and growing mental health awareness contribute to steady demand.

France

France benefits from integrated mental health services and increasing diagnosis of anxiety disorders.

Italy and Spain

Lifestyle stressors, economic pressures, and improved recognition of mental health conditions drive moderate growth.

Japan

Rising mental health awareness and gradual reduction in stigma are expanding treatment-seeking behavior, particularly among younger populations.

Competitive Landscape

The panic disorder market includes global pharmaceutical companies with established psychiatric portfolios and ongoing R&D efforts.

Key Companies Covered

Teva Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd

Mylan

AstraZeneca

Abbott

Baxter

Bristol-Myers Squibb Company

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

GlaxoSmithKline plc

Recordati S.p.A.

Boehringer Ingelheim International GmbH

Neurocrine Biosciences, Inc.

Sanofi

These companies focus on maintaining strong portfolios of antidepressants and anxiolytics while exploring improved formulations and adjunct therapies.

Challenges in the Panic Disorder Market

Despite growth opportunities, the market faces notable challenges:

Underdiagnosis due to symptom overlap and stigma

Long-term medication adherence issues

Side effects and dependency concerns

Limited access to psychotherapy in some regions

Variability in treatment response among patients

Addressing these challenges requires coordinated efforts across healthcare systems, policy frameworks, and innovation pipelines.

Future Outlook: Panic Disorder Market (2026-2035)

The future of the Panic Disorder Market is expected to be shaped by integrated care models and patient-centric treatment approaches. Key developments anticipated over the forecast period include:

Wider adoption of digital CBT and telepsychiatry

Improved pharmacological safety profiles

Greater focus on early intervention and prevention

Expanded mental health coverage and policy support

Increased emphasis on quality-of-life outcomes

By 2035, panic disorder management is likely to become more personalized, accessible, and holistic.

See More Reports

Nootropics Market - https://bit.ly/4oNrHvd.

United States Topical Pain Relief Market - https://bit.ly/43Fje4N.

Oxygen Therapy Market - https://www.linkedin.com/pulse/oxygen-therapy-market-outlook-industry-analysis-2035-roshan-kumar-hgytc.

North America Clinical Trials Market - https://www.linkedin.com/pulse/north-america-clinical-trials-market-size-outlook-2035-roshan-kumar-eipjc.

Media Contact

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.